rs10204525 binding to miR-4717-3p modulates PD-1 expression and predicts the development of immune-related adverse events in patients with advanced cancer treated with anti-PD-1/PD-L1 therapy
Giovanna Polcaro(University of Salerno), Francesco Sabbatino(University of Salerno)
Cited by 1
Related Papers
Blocking the formation of radiation-induced breast cancer stem cells
|Oncotarget|2014|109